These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27233969)

  • 1. Differences in cognitive impairment between schizophrenia and bipolar disorder: Considering the role of heterogeneity.
    Bora E
    Psychiatry Clin Neurosci; 2016 Oct; 70(10):424-433. PubMed ID: 27233969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental Differences Between Schizophrenia and Bipolar Disorder.
    Parellada M; Gomez-Vallejo S; Burdeus M; Arango C
    Schizophr Bull; 2017 Oct; 43(6):1176-1189. PubMed ID: 29045744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.
    Menkes MW; Armstrong K; Blackford JU; Heckers S; Woodward ND
    Schizophr Res; 2019 Apr; 206():413-419. PubMed ID: 31104720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum.
    Van Rheenen TE; Lewandowski KE; Tan EJ; Ospina LH; Ongur D; Neill E; Gurvich C; Pantelis C; Malhotra AK; Rossell SL; Burdick KE
    Psychol Med; 2017 Jul; 47(10):1848-1864. PubMed ID: 28241891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia.
    Bora E; Özerdem A
    Psychol Med; 2017 Dec; 47(16):2753-2766. PubMed ID: 28585513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.
    Sheffield JM; Karcher NR; Barch DM
    Neuropsychol Rev; 2018 Dec; 28(4):509-533. PubMed ID: 30343458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental trajectory of cognitive impairment in bipolar disorder: comparison with schizophrenia.
    Bora E
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):158-68. PubMed ID: 25261263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive heterogeneity in young offspring of patients with bipolar disorder: The effect of putative clinical stages.
    Bora E; Can G; Ildız A; Ulas G; Ongun CH; Inal NE; Ozerdem A
    J Affect Disord; 2019 Oct; 257():130-135. PubMed ID: 31301613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive endophenotypes in schizophrenia and bipolar disorder: A systematic review of longitudinal family studies.
    Luperdi SC; Tabarés-Seisdedos R; Livianos L; Vieta E; Cuesta MJ; Balanzá-Martínez V
    Schizophr Res; 2019 Aug; 210():21-29. PubMed ID: 31272906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? A systematic review and meta-analysis.
    Trotta A; Murray RM; MacCabe JH
    Psychol Med; 2015 Jan; 45(2):381-94. PubMed ID: 25065268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theory of mind impairment and its clinical correlates in patients with schizophrenia, major depressive disorder and bipolar disorder.
    Wang YY; Wang Y; Zou YM; Ni K; Tian X; Sun HW; Lui SSY; Cheung EFC; Suckling J; Chan RCK
    Schizophr Res; 2018 Jul; 197():349-356. PubMed ID: 29122405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder.
    Reilly JL; Hill SK; Gold JM; Keefe RS; Clementz BA; Gershon E; Keshavan MS; Pearlson G; Tamminga CA; Sweeney JA
    Schizophr Bull; 2017 Mar; 43(2):397-406. PubMed ID: 27306316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive subtypes in patients with bipolar disorder and their unaffected siblings.
    Russo M; Van Rheenen TE; Shanahan M; Mahon K; Perez-Rodriguez MM; Cuesta-Diaz A; Larsen E; Malhotra AK; Burdick KE
    Psychol Med; 2017 Dec; 47(16):2892-2905. PubMed ID: 28587689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and developmental characteristics of cognitive subgroups in a transdiagnostic sample of schizophrenia spectrum disorders and bipolar disorder.
    Bora E; Verim B; Akgul O; Ildız A; Ceylan D; Alptekin K; Özerdem A; Akdede BB
    Eur Neuropsychopharmacol; 2023 Mar; 68():47-56. PubMed ID: 36640733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive enhancing agents in schizophrenia and bipolar disorder.
    Vreeker A; van Bergen AH; Kahn RS
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):969-1002. PubMed ID: 25957798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theory of mind and executive functions in schizophrenia and bipolar disorder: A cross-diagnostic latent class analysis for identification of neuropsychological subtypes.
    Bora E; Veznedaroğlu B; Vahip S
    Schizophr Res; 2016 Oct; 176(2-3):500-505. PubMed ID: 27317360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical evidence for discrete neurocognitive subgroups in patients with non-psychotic major depressive disorder: clinical implications.
    Pu S; Noda T; Setoyama S; Nakagome K
    Psychol Med; 2018 Dec; 48(16):2717-2729. PubMed ID: 29679991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects.
    Ohi K; Nishizawa D; Sugiyama S; Takai K; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
    Int J Neuropsychopharmacol; 2021 Jul; 24(7):562-569. PubMed ID: 33738471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review.
    Misiak B; Stańczykiewicz B; Kotowicz K; Rybakowski JK; Samochowiec J; Frydecka D
    Schizophr Res; 2018 Feb; 192():16-29. PubMed ID: 28416092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls.
    Bora E; Pantelis C
    Schizophr Bull; 2015 Sep; 41(5):1095-104. PubMed ID: 25616505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.